Pulmonary fibrosis(PF)is a chronic progressive lung disease caused by a variety of etiologies and is also a common outcome of various chronic inflammatory lung diseases.The incidence of pulmonary fibrosis is increasing year by year,with a high mortality rate that seriously threatens the life and health of patients.Although two drugs,pirfenidone and nintedanib,are already on the market for the treatment of pulmonary fibrosis,they can only slow down the progression of the disease but cannot reverse or stop the process of pulmonary fibrosis,and long-term use can produce a variety of adverse reactions.Therefore,it is highly necessary to develop new drugs for pulmonary fibrosis that are more targeted,effective,and well-tolerated by patients.The phosphatidylinositol-3-kinase(PI3K)signaling pathway plays an important role in the pathogenesis of pulmonary fibrosis.Targeted inhibition of the PI3K signaling pathway may be an important direction for the development of new drugs for pulmonary fibrosis.At present,some PI3K signaling pathway inhibitors have shown good effects in preventing and treating pulmonary fibrosis,but most of them are still in the research stage.This article reviews the role of the PI3K signaling pathway in PF,further summarizes promising PI3K pathway inhibitors with PF therapeutic effects,including inhibitors in clinical trials and preclinical studies,and discusses their mechanisms of action and development prospects.

Objective To study the temozolomide combined with curcumin on the inhibitory effect and apoptosis of the C6 glioma cells. Methods The C6 glioma cells were treated with temozomide in combination with curcumin. The anti proliferation effect of liposomes on the C6 glioma cells was investigated by using the method of sulforhodamine B (SRB). Flow cytometry was used to detect apoptosis of the C6 glioma cells. Confocal laser scan-ning microscope was used to observe apoptosis and location in the C6 glioma cells. Results The results of SRB as-say showed that temozolomide in combination with curcumin inhibition rate were (91.22 ± 0.51)%in 48 h of the C6 glioma cells; Flow cytometry showed that the apoptosis rate were (33.15 ± 0.79)% with temozolomide (5 μmol/L) in combination with curcumin (10 μmol/L). Laser scanning confocal scanning microscope indicated that the apop-tosis of in the C6 glioma cells treated with temozolomide in combination with curcumin was more than that of free drug. Conclusion The temozolomide in combination of curcumin can inhibit the growth and induce apoptosis of the C6 glioma cells.